Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases

被引：0
|
作者：
Marc Humbert
Gérald Simonneau
机构：
[1] Professors of Respiratory Medicine at the Center for Pulmonary Vascular Diseases,
[2] Service de Pneumologie et Réanimation Respiratoire,undefined
[3] Hôpital Antoine Béclère,undefined
[4] Assistance-Publique Hôpitaux de Paris,undefined
[5] Université Paris-Sud,undefined
来源：
Nature Clinical Practice Rheumatology | 2005年 / 1卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Pulmonary arterial hypertension is particularly common in individuals with systemic sclerosis, but is also seen in other rheumatic diseases. A number of treatment optionsfor this serious complication are available, including selective and unselective endothelin-receptor antagonists, which are the subject of this review.
引用
收藏
页码：93 / 101
页数：8
相关论文
共 50 条
12345